BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 16566360)

  • 1. [Prophylactics of cervical cancer in Polish female population aged 45-54].
    Bińkowska M; Debski R
    Ginekol Pol; 2005 Nov; 76(11):863-70. PubMed ID: 16566360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Screening mammography in Polish female population aged 45 to 54].
    Bińkowska M; Debski R
    Ginekol Pol; 2005 Nov; 76(11):871-8. PubMed ID: 16566361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Attendance rate in the Polish Cervical Cancer Screening Program in the years 2007-2009].
    Spaczyński M; Karowicz-Bilinska A; Rokita W; Molińska-Glura M; Januszek-Michalecka L; Seroczyński P; Uchlik J; Nowak-Markwitz E
    Ginekol Pol; 2010 Sep; 81(9):655-63. PubMed ID: 20973201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cervical cancer screening in Poland and worldwide].
    Spaczyński M; Nowak-Markwitz E; Kedzia W
    Ginekol Pol; 2007 May; 78(5):354-60. PubMed ID: 17867325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Women's social conditions and their participation in Cervical Cancer Population Screening Program in Poland].
    Spaczyński M; Nowak-Markwitz E; Januszek-Michalecka L; Karowicz-Bilińska A
    Ginekol Pol; 2009 Nov; 80(11):833-8. PubMed ID: 20088397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Estimated results of prophylactic physical examinations detecting cervical cancer in Center of Oncology in Bydgoszcz in years 2001-2003].
    Mierzwa T; Grabiec M; Walentowicz M
    Ginekol Pol; 2005 Sep; 76(9):693-8. PubMed ID: 16417080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Costs of population cervical cancer screening program in Poland between 2007-2009].
    Spaczyński M; Karowicz-Bilinska A; Kedzia W; Molińska-Glura M; Seroczyński P; Januszek-Michalecka L; Rokita W; Nowak-Markwitz E
    Ginekol Pol; 2010 Oct; 81(10):750-6. PubMed ID: 21117303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Awareness of cervical cancer prevention among patients of gynecological outpatient clinic].
    Ulman-Włodarz I; Nowosielski K; Romanik M; Pozowski J; Jurek M
    Ginekol Pol; 2011 Jan; 82(1):22-5. PubMed ID: 21473052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervical cancer in Poland: awareness, survival and therapy. Population based studies.
    Jokiel M; Bielska-Lasota M
    Przegl Epidemiol; 2005; 59(4):915-21. PubMed ID: 16729433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prophylactic medical investigations for breast cancer and uterine cervix cancer in Regional Oncology Centre of Bydgoszcz in 2003].
    Mierzwa T; Grabiec M
    Wiad Lek; 2004; 57 Suppl 1():207-10. PubMed ID: 15884240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cervical cancer in Poland and in the world--in the light of incidence and mortality data].
    Nowakowski AM; Kotarski J
    Przegl Epidemiol; 2011; 65(1):75-9. PubMed ID: 21735841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barriers and missed opportunities in breast and cervical cancer screening among women aged 50 and over, New York City, 2002.
    Nash D; Chan C; Horowitz D; Vlahov D
    J Womens Health (Larchmt); 2007; 16(1):46-56. PubMed ID: 17324096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Community-randomised controlled trial embedded in the Anishinaabek Cervical Cancer Screening Study: human papillomavirus self-sampling versus Papanicolaou cytology.
    Zehbe I; Jackson R; Wood B; Weaver B; Escott N; Severini A; Krajden M; Bishop L; Morrisseau K; Ogilvie G; Burchell AN; Little J
    BMJ Open; 2016 Oct; 6(10):e011754. PubMed ID: 27855089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survey on the trends in uterine cervical cancer screening in Japanese women: the efficacy of free coupons in the screening.
    Kuroki H
    J Obstet Gynaecol Res; 2012 Jan; 38(1):35-9. PubMed ID: 21995720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do you still need a Pap test?
    Johns Hopkins Med Lett Health After 50; 2012 Feb; 23(12):6. PubMed ID: 22397002
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of a mobile unit on changes in knowledge and use of cervical cancer screening among rural Thai women.
    Swaddiwudhipong W; Chaovakiratipong C; Nguntra P; Mahasakpan P; Lerdlukanavonge P; Koonchote S
    Int J Epidemiol; 1995 Jun; 24(3):493-8. PubMed ID: 7672887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uptake of breast and cervical cancer screening in four Gulf Cooperation Council countries.
    So VHT; Channon AA; Ali MM; Merdad L; Al Sabahi S; Al Suwaidi H; Al Ajeel A; Osman N; Khoja TAM
    Eur J Cancer Prev; 2019 Sep; 28(5):451-456. PubMed ID: 30260812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prophylactic medical examinations for breast cancer and uterine cervix cancer in Regional Oncological Center of Bydgoszcz in year 2002].
    Mierzwa T; Siwek P; Grabiec M
    Ginekol Pol; 2003 Sep; 74(9):811-6. PubMed ID: 14674129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-reported history of Pap-smear in HIV-positive women in Northern Italy: a cross-sectional study.
    Dal Maso L; Franceschi S; Lise M; De' Bianchi PS; Polesel J; Ghinelli F; Falcini F; Finarelli AC;
    BMC Cancer; 2010 Jun; 10():310. PubMed ID: 20565935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barriers to cervical cancer screening in women attending the Family Medical Program in Niterói, Rio de Janeiro.
    Augusto EF; Rosa ML; Cavalcanti SM; Oliveira LH
    Arch Gynecol Obstet; 2013 Jan; 287(1):53-8. PubMed ID: 22886356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.